Faculty Opinions recommendation of Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: a phase II study.

2013 ◽  
Author(s):  
Piero Portincasa ◽  
Leonilde Bonfrate
Keyword(s):  
Folinic Acid ◽  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Hepatic Arterial Infusion ◽  
Arterial Infusion ◽  
Tract Cancer

Hepatic Arterial Infusion with Oxaliplatin and 5-FU/Folinic Acid for Advanced Biliary Tract Cancer: A Phase II Study

2013 ◽  
Vol 58 (8) ◽  
pp. 2399-2405 ◽  
Author(s):  
M. Sinn ◽  
A. Nicolaou ◽  
B. Gebauer ◽  
P. Podrabsky ◽  
D. Seehofer ◽  
...  
Keyword(s):  
Folinic Acid ◽  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Hepatic Arterial Infusion ◽  
Arterial Infusion ◽  
Tract Cancer

scholarly journals Chemotherapy of biliary tract cancer with mitomycin-C and 5-fluorouracil biologically modulated by folinic acid. A phase II study

1996 ◽  
Vol 7 (6) ◽  
pp. 644-645 ◽  
Author(s):  
A. Polyzos ◽  
Georges Nikou ◽  
A. Giannopoulos ◽  
A. Toskas ◽  
N. Kalahanis ◽  
...  
Keyword(s):  
Folinic Acid ◽  
Mitomycin C ◽  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Tract Cancer

Phase II Study of Cisplatin, Epirubicin, and Continuous-Infusion 5-Fluorouracil for Advanced Biliary Tract Cancer

Oncology ◽  
2003 ◽  
Vol 64 (4) ◽  
pp. 475-476 ◽  
Author(s):  
Chigusa Morizane ◽  
Shuichi Okada ◽  
Takuji Okusaka ◽  
Hideki Ueno ◽  
Toshimitsu Saisho
Keyword(s):  
Continuous Infusion ◽  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Tract Cancer

scholarly journals Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)

ESMO Open ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 100314
Author(s):  
M.M. Javle ◽  
D.-Y. Oh ◽  
M. Ikeda ◽  
W.-P. Yong ◽  
K. Hsu ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Second Line ◽  
Tract Cancer ◽  
Randomized Phase Ii

scholarly journals Phase II study of evofosfamide (TH-302) monotherapy as a second-line treatment in advanced biliary tract cancer

2018 ◽  
Vol 29 ◽  
pp. viii259
Author(s):  
J.S. Yoon ◽  
K.-H. Lee ◽  
G.J. Cheon ◽  
Y.-J. Bang ◽  
D.-Y. Oh
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Biliary Tract Cancer ◽  
Phase Ii Study ◽  
Line Treatment ◽  
Second Line ◽  
Tract Cancer
Sign in / Sign up

Export Citation Format

Share Document